Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 1;40(19):e108863.
doi: 10.15252/embj.2021108863. Epub 2021 Aug 30.

Autophagy in major human diseases

Daniel J Klionsky  1 Giulia Petroni  2 Ravi K Amaravadi  3   4 Eric H Baehrecke  5 Andrea Ballabio  6   7   8 Patricia Boya  9 José Manuel Bravo-San Pedro  10   11 Ken Cadwell  12   13   14 Francesco Cecconi  15   16   17 Augustine M K Choi  18   19 Mary E Choi  19   20 Charleen T Chu  21 Patrice Codogno  22   23 Maria Isabel Colombo  24 Ana Maria Cuervo  25   26 Vojo Deretic  27   28 Ivan Dikic  29   30 Zvulun Elazar  31 Eeva-Liisa Eskelinen  32 Gian Maria Fimia  33   34 David A Gewirtz  35 Douglas R Green  36 Malene Hansen  37 Marja Jäättelä  38   39 Terje Johansen  40 Gábor Juhász  41   42 Vassiliki Karantza  43 Claudine Kraft  44   45 Guido Kroemer  46   47   48   49   50 Nicholas T Ktistakis  51 Sharad Kumar  52   53 Carlos Lopez-Otin  54   55 Kay F Macleod  56   57 Frank Madeo  58   59   60 Jennifer Martinez  61 Alicia Meléndez  62   63 Noboru Mizushima  64 Christian Münz  65 Josef M Penninger  66   67 Rushika M Perera  68   69   70 Mauro Piacentini  71   72 Fulvio Reggiori  73 David C Rubinsztein  74   75 Kevin M Ryan  76   77 Junichi Sadoshima  78 Laura Santambrogio  2   79   80 Luca Scorrano  81   82 Hans-Uwe Simon  83   84   85 Anna Katharina Simon  86 Anne Simonsen  87   88   89 Alexandra Stolz  29   30 Nektarios Tavernarakis  90   91 Sharon A Tooze  92 Tamotsu Yoshimori  93   94   95 Junying Yuan  96   97 Zhenyu Yue  98 Qing Zhong  99 Lorenzo Galluzzi  2   79   80   100   23 Federico Pietrocola  101
Affiliations
Review

Autophagy in major human diseases

Daniel J Klionsky et al. EMBO J. .

Abstract

Autophagy is a core molecular pathway for the preservation of cellular and organismal homeostasis. Pharmacological and genetic interventions impairing autophagy responses promote or aggravate disease in a plethora of experimental models. Consistently, mutations in autophagy-related processes cause severe human pathologies. Here, we review and discuss preclinical data linking autophagy dysfunction to the pathogenesis of major human disorders including cancer as well as cardiovascular, neurodegenerative, metabolic, pulmonary, renal, infectious, musculoskeletal, and ocular disorders.

Keywords: aging; cancer; inflammation; metabolic syndromes; neurodegeneration.

PubMed Disclaimer

Conflict of interest statement

A.B. is cofounder of CASMA Therapeutics Inc., Advisory Board member of Next Generation Diagnostics and of Avilar Therapeutics. K.C. has received research support from Pfizer, Takeda, Pacific Biosciences, and AbbVie; consulted for or received an honorarium from PureTech Health, Genentech, and AbbVie; and holds U.S. patent 10,722,600 and provisional patents 62/935,035 and 63/157,225. A.M.K.C. is a cofounder, stock holder and serves on the Scientific Advisory Board for Proterris, which develops therapeutic uses for carbon monoxide. A.M.K.C. also has a use patent on CO. G.K is a cofounder and advisor of EverImmune, Samsara Therapeutics, and Therafast Bio as well as advisor for The Longevity Labs (TLL). F.M. is a founder, is advisor, and has equity interests in The Longevity Labs (TLL) and Samara Therapeutics. D.C.R is a consultant for Aladdin Healthcare Technologies SE, Drishti Discoveries, and Nido Biosciences. L.G. has received research funding from Lytix Biopharma and Phosplatin, as well as consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, and the Luke Heller TECPR2 Foundation. RKA is cofounder of Pinpoint Therapeutics and advisor for Deciphera, Sprint Biosciences, Merck, and Immunacell. He gets research funding for clinical trials from Novartis, Bristol Myers Squibb, Pfizer, and Deciphera. J.Y. is a consultant for Denali Therapeutics, Sanofi, and Nido. All other authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1. Common human disorders linked to dysregulated autophagic activity
Representation of the main organ‐specific (red) and systemic (blue) human illnesses in which autophagy plays a critical role and that are discussed in this review. ALS, amyotrophic lateral sclerosis; COPD, chronic obstructive pulmonary disease; DKD, diabetic kidney disease; NAFLD, non‐alcoholic fatty liver disease; PDB, Paget disease of bone.
Figure 2
Figure 2. Basic principles of autophagy modulation as a therapeutic strategy for human disease
In multiple settings including various neurodegenerative conditions, autophagy defects contribute to disease onset and progression, suggesting that autophagy activators may mediate beneficial effects. Conversely, proficient autophagic responses support tumor progression and resistance to therapy, pointing to autophagy inhibition as an appropriate therapeutic approach. In both scenarios, the effect of autophagy modulation on non‐diseased cells must be carefully considered to enable safety and superior therapeutic efficacy.

References

    1. Abdel Fattah E, Bhattacharya A, Herron A, Safdar Z, Eissa NT (2015) Critical role for IL‐18 in spontaneous lung inflammation caused by autophagy deficiency. J Immunol 194: 5407–5416 - PMC - PubMed
    1. Abebe T, Mahadevan J, Bogachus L, Hahn S, Black M, Oseid E, Urano F, Cirulli V, Robertson RP (2017) Nrf2/antioxidant pathway mediates beta cell self‐repair after damage by high‐fat diet‐induced oxidative stress. JCI Insight 2: e92854 - PMC - PubMed
    1. Aden K, Tran F, Ito GO, Sheibani‐Tezerji R, Lipinski S, Kuiper JW, Tschurtschenthaler M, Saveljeva S, Bhattacharyya J, Häsler Ret al (2018) ATG16L1 orchestrates interleukin‐22 signaling in the intestinal epithelium via cGAS‐STING. J Exp Med 215: 2868–2886 - PMC - PubMed
    1. Adolph TE, Tomczak MF, Niederreiter L, Ko H‐J, Böck J, Martinez‐Naves E, Glickman JN, Tschurtschenthaler M, Hartwig J, Hosomi Set al (2013) Paneth cells as a site of origin for intestinal inflammation. Nature 503: 272–276 - PMC - PubMed
    1. Aghajan M, Li N, Karin M (2012) Obesity, autophagy and the pathogenesis of liver and pancreatic cancers. J Gastroenterol Hepatol 27(Suppl 2): 10–14 - PMC - PubMed